BR vs NRIX · P/E 16, rev $6.89B vs rev $54.5M
Broadridge Financial Solutions Inc (BR) versus Nurix Therapeutics Inc (NRIX) — a side-by-side from cached financials, not a winner call.
Broadridge Financial Solutions Inc (BR) is a information technology services company listed on US.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Latest reported BR revenue for 2025-06-30 was $6.89B. Net income was $839.5M. Revenue was up 5.9% from 2024-06-30 to 2025-06-30. BR currently screens at market cap $17.65B and trailing P/E 16.3.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
BR currently screens at market cap $17.65B and trailing P/E 16.3. NRIX currently screens at market cap $1.77B.
Not investment advice. Open the BR and NRIX stock pages for the full models.
Not investment advice.